METHOD FOR DEFINING FORM OF ESSENTIAL ARTERIAL HYPERTENSION IN CHILDREN AND ADOLESCENTS Russian patent published in 2014 - IPC A61B5/02 A61B5/145 

FIELD: medicine.

SUBSTANCE: left ventricular systolic volume as shown by echocardiography is determined in the children and adolescents suffering from essential arterial hypertension; blood serum lead is measured, and a systolic day-time hypertension time index is calculated by a regression analysis formula: SAT TI day-time=0.12+0.0035*SV+0.13*Pb blood serum, wherein SAT TI day-time is the systolic day-time hypertension time index; SV is the left ventricular systolic volume as shown by echocardiography; Pb blood serum is the blood serum lead content. If the systolic day-time hypertension time index falls within the range of 0.25 to 0.50, the form of essential arterial hypertension is considered to be labile, and if the value is more than 0.50, the stable form of essential arterial hypertension is stated.

EFFECT: method enables defining the form of essential arterial hypertension in the children and adolescents by measuring the blood serum lead content as shown by atomic absorption spectrophotometry and determining the left ventricular systolic volume according to echocardiography.

1 tbl, 3 ex